myirislogo
06 March, 2015 16:32 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
I T C 345.95 0.45
State Bank O 293.65 0.19
Hindalco In 147.90 3.36
Axis Bank 616.60 0.64
Tata Stl 343.40 1.28
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Natco Pharma Limited
Natco Pharma Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:524816NSE:NATCOPHARMBloomberg:NTCPH@INReuters:NATP.BO
Market Lot: 1Face Value: 10ISIN Demat: INE987B01018
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
11-FEB-15 Natco Pharma announced today that its marketing partner, Mylan, has filed an Abbreviated New Drug Application (ANDA) for Sorafenib Tablets, 200mg, with the US Federal Drug Administration (USFDA). 11-FEB-15 During the quarter, the profit of the company declined 48.77% to Rs 166.10 million from Rs 324.20 million in the same quarter previous year 10-FEB-15 Natco Pharma, one of the few Indian companies to venture into new drug discover...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
NATCO announces licensing agreement with Gilead Sciences  -IRIS 02-Mar-15
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2014(3)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 1620.005720.405143.30
Other Income8.80157.10119.40
Total Income1628.805877.505262.70
Cost of goods sold1209.204357.504023.30
OPBDIT419.601520.001239.40
PAT364.101101.90781.30
Gross Block---
Equity capital330.70330.70313.70
EPS (Rs.)-34.4924.91
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-11.31 - 25.4313.25 - 20.28
Debt / Equity (x)---
Operating margin (% of OI)25.825.923.6
Net margin (% of OI)22.418.714.8
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Natco House
Road No 2
Banjara Hills
Hyderabad
Andhra Pradesh-500 033
PHONE
(040) 2354 7532
FAX
(040) 2354 8243
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer